1. An Anti-Tumour immune response is associated with favourable outcomes and a local inflammatory response represented by CD8+ cytotoxic lymphocyte infiltration within the tumour. 2. A Tumour promoting immune response is associated with poorer outcomes and a systemic inflammatory response represented by markers such as elevated neutrophil-lymphocyte ratio, high C-reactive protein.

Table 2: Differing outcomes from the tumour associated immune response.